-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation